• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.随机对照试验与基于人群的观察性研究：医学证据发展中的合作伙伴。
Br J Cancer. 2014 Feb 4;110(3):551-5. doi: 10.1038/bjc.2013.725. Epub 2014 Jan 14.
2
Informative value of Patient Reported Outcomes (PRO) in Health Technology Assessment (HTA).患者报告结局（PRO）在卫生技术评估（HTA）中的信息价值。
GMS Health Technol Assess. 2011 Feb 2;7:Doc01. doi: 10.3205/hta000092.
3
Comparative effectiveness research in oncology: the need for clarity, transparency and vision.肿瘤学中的比较疗效研究：明确性、透明度与愿景的必要性。
Cancer Invest. 2009 Jul;27(6):593-7. doi: 10.1080/07357900903109952.
4
Bone graft substitutes for the treatment of traumatic fractures of the extremities.用于治疗四肢创伤性骨折的骨移植替代物。
GMS Health Technol Assess. 2012;8:Doc04. doi: 10.3205/hta000102. Epub 2012 Jun 14.
5
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks.提供有意义的癌症护理：一项使用 ASCO 和 ESMO 框架评估成本和效益的回顾性队列研究。
Lancet Oncol. 2017 Jul;18(7):887-894. doi: 10.1016/S1470-2045(17)30415-1. Epub 2017 Jun 2.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Investigating the cost-effectiveness of videotelephone based support for newly diagnosed paediatric oncology patients and their families: design of a randomised controlled trial.调查基于视频电话对新诊断的儿科肿瘤患者及其家庭的支持的成本效益：一项随机对照试验的设计
BMC Health Serv Res. 2007 Mar 5;7:38. doi: 10.1186/1472-6963-7-38.
8
[Evidence-based medicine in surgical oncology].[外科肿瘤学中的循证医学]
Zentralbl Chir. 2001 Apr;126(4):253.
9
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.成人癫痫新药的临床疗效、耐受性及成本效益：一项系统评价与经济学评估
Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. doi: 10.3310/hta9150.
10
'Not clinically effective but cost-effective' - paradoxical conclusions in randomised controlled trials with 'doubly null' results: a cross-sectional study.“无临床疗效但具有成本效益”——具有“双重无效”结果的随机对照试验中的矛盾结论：一项横断面研究。
BMJ Open. 2020 Jan 9;10(1):e029596. doi: 10.1136/bmjopen-2019-029596.

引用本文的文献

1
[Not Available].[无可用内容]。
Glob Reg Health Technol Assess. 2025 Sep 5;12:198-204. doi: 10.33393/grhta.2025.3568. eCollection 2025 Jan-Dec.
2
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study.瑞戈非尼用于真实世界实践中的肝细胞癌（REFINE）：一项前瞻性观察性研究。
Liver Cancer. 2024 Dec 18;14(4):391-407. doi: 10.1159/000542285. eCollection 2025 Aug.
3
How to quantify between-study heterogeneity in single-arm evidence synthesis?-It depends!如何在单臂证据综合中量化研究间异质性？这要看情况！
Syst Rev. 2025 Jul 5;14(1):138. doi: 10.1186/s13643-025-02831-1.
4
Patient Experiences Regarding Feasibility of Implementing Real-World EQ-5D Collection at an Oncology Centre in Ontario, Canada.加拿大安大略省一家肿瘤中心患者对实施真实世界EQ-5D数据收集可行性的体验
Curr Oncol. 2025 May 27;32(6):308. doi: 10.3390/curroncol32060308.
5
Changes in opioid distribution and chronic opioid users following outpatient orthopedic surgery: a pre-post intervention study.门诊骨科手术后阿片类药物分布及慢性阿片类药物使用者的变化：一项干预前后研究
Can J Surg. 2025 Jun 18;68(3):E265-E270. doi: 10.1503/cjs.000325. Print 2025 May-Jun.
6
Trends in surgical stabilization of rib fractures: A contemporary literature review.肋骨骨折手术固定的趋势：当代文献综述
J Clin Orthop Trauma. 2025 Apr 23;66:103028. doi: 10.1016/j.jcot.2025.103028. eCollection 2025 Jul.
7
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).韩国HR（+）、HER2（-）转移性乳腺癌患者中帕博西尼的全国真实世界实践模式和临床数据（KCSG BR21-15）
Breast. 2025 May 12;82:104500. doi: 10.1016/j.breast.2025.104500.
8
Long-term quality of life, vulvar symptoms, and sexual functioning: A cross-sectional study of Norwegian vulvar cancer survivors.长期生活质量、外阴症状及性功能：挪威外阴癌幸存者的横断面研究
Acta Obstet Gynecol Scand. 2025 Aug;104(8):1505-1516. doi: 10.1111/aogs.15155. Epub 2025 May 14.
9
Populations Addressed in Vaccines Approved via the European Medicines Agency.通过欧洲药品管理局批准的疫苗所针对的人群。
Clin Pharmacol Ther. 2025 Aug;118(2):459-469. doi: 10.1002/cpt.3694. Epub 2025 May 5.
10
Assessing the Value of Integrated Evidence Approaches in Drug Development.评估综合证据方法在药物研发中的价值。
Ther Innov Regul Sci. 2025 Apr 23. doi: 10.1007/s43441-025-00778-y.

本文引用的文献

1
Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993.肾上腺皮质癌：自 1993 年以来荷兰基于人群的发病率和生存研究。
Eur J Cancer. 2013 Jul;49(11):2579-86. doi: 10.1016/j.ejca.2013.02.034. Epub 2013 Apr 3.
2
Risk of ischemic heart disease in women after radiotherapy for breast cancer.乳腺癌放疗后女性患缺血性心脏病的风险。
N Engl J Med. 2013 Mar 14;368(11):987-98. doi: 10.1056/NEJMoa1209825.
3
Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study.与非小细胞肺癌患者转至肿瘤内科就诊及随后接受辅助化疗相关的因素：一项基于人群的研究。
Curr Oncol. 2013 Feb;20(1):30-7. doi: 10.3747/co.20.1178.
4
Evaluation of treatment benefit in Journal of Clinical Oncology.《临床肿瘤学杂志》中治疗益处的评估。
J Clin Oncol. 2013 Mar 20;31(9):1123-4. doi: 10.1200/JCO.2012.47.6952. Epub 2013 Jan 28.
5
Bias in reporting of end points of efficacy and toxicity in randomized, clinical trials for women with breast cancer.乳腺癌女性随机临床试验中疗效和毒性终点报告的偏倚。
Ann Oncol. 2013 May;24(5):1238-44. doi: 10.1093/annonc/mds636. Epub 2013 Jan 9.
6
Patient income level and cancer clinical trial participation.患者收入水平与癌症临床试验参与度。
J Clin Oncol. 2013 Feb 10;31(5):536-42. doi: 10.1200/JCO.2012.45.4553. Epub 2013 Jan 7.
7
Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study.基于人群的研究：食管癌手术后生存率与医院和外科医生手术量的关系。
J Clin Oncol. 2013 Feb 10;31(5):551-7. doi: 10.1200/JCO.2012.46.1517. Epub 2013 Jan 7.
8
Comparative effectiveness research in oncology methodology: observational data.肿瘤学方法中的比较疗效研究：观察性数据。
J Clin Oncol. 2012 Dec 1;30(34):4215-22. doi: 10.1200/JCO.2012.41.6701. Epub 2012 Oct 15.
9
Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.在既往接受基于奥沙利铂方案治疗的转移性结直肠癌患者中，阿柏西普联合氟尿嘧啶、亚叶酸钙和伊立替康可改善生存，这在一项 III 期随机试验中得到证实。
J Clin Oncol. 2012 Oct 1;30(28):3499-506. doi: 10.1200/JCO.2012.42.8201. Epub 2012 Sep 4.
10
The price we pay for progress: a meta-analysis of harms of newly approved anticancer drugs.我们为进步付出的代价：新批准的抗癌药物危害的荟萃分析。
J Clin Oncol. 2012 Aug 20;30(24):3012-9. doi: 10.1200/JCO.2011.40.3824. Epub 2012 Jul 16.

Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence.

作者信息

Booth C M, Tannock I F

机构信息

Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, 10 Stuart Street, Kingston, ON K7L 5PG, Canada.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.

出版信息

Br J Cancer. 2014 Feb 4;110(3):551-5. doi: 10.1038/bjc.2013.725. Epub 2014 Jan 14.

DOI:10.1038/bjc.2013.725
PMID:24495873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3915111/
Abstract
摘要